Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Su

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Obstetrics and Gynecology|October 17, 2015
Congenital syphilis: trends in mortality and morbidity in the United States, 1999 through 2013John R Su, Lesley C Brooks, Darlene W Davis, et al.
Pediatrics|November 20, 2019
Safety of the 9-Valent Human Papillomavirus VaccineTom T Shimabukuro, John R Su, Paige L Marquez, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2019
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016John R Su, Pedro L Moro, Carmen S Ng, et al.
Vaccine|January 10, 2021
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018John R Su, Michael M McNeil, Kerry J Welsh, et al.
Drug Safety|February 27, 2024
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS)Pedro L Moro, Carol Ennulat, Hannah Brown, et al.
Sexually Transmitted Diseases|February 15, 2011
Epidemiology of syphilis among Hispanic women and associations with congenital syphilis, Maricopa county, ArizonaRobert D Kirkcaldy, John R Su, Melanie M Taylor, et al.
Pediatrics|February 9, 2017
Safety of Second-Dose Single-Antigen Varicella VaccineJohn R Su, Zanie Leroy, Paige W Lewis, et al.
Vaccine|December 25, 2019
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017John R Su, Penina Haber, Carmen S Ng, et al.
Vaccine|June 15, 2023
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022Emily Jane Woo, Julianne Gee, Paige Marquez, et al.
Vaccine|January 20, 2023
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022Pedro L Moro, Bicheng Zhang, Carol Ennulat, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Obstetrics and Gynecology|October 17, 2015
Congenital syphilis: trends in mortality and morbidity in the United States, 1999 through 2013John R Su, Lesley C Brooks, Darlene W Davis, et al.
Pediatrics|November 20, 2019
Safety of the 9-Valent Human Papillomavirus VaccineTom T Shimabukuro, John R Su, Paige L Marquez, et al.
The Journal of Allergy and Clinical Immunology|January 18, 2019
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016John R Su, Pedro L Moro, Carmen S Ng, et al.
Vaccine|January 10, 2021
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018John R Su, Michael M McNeil, Kerry J Welsh, et al.
Drug Safety|February 27, 2024
Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS)Pedro L Moro, Carol Ennulat, Hannah Brown, et al.
Sexually Transmitted Diseases|February 15, 2011
Epidemiology of syphilis among Hispanic women and associations with congenital syphilis, Maricopa county, ArizonaRobert D Kirkcaldy, John R Su, Melanie M Taylor, et al.
Pediatrics|February 9, 2017
Safety of Second-Dose Single-Antigen Varicella VaccineJohn R Su, Zanie Leroy, Paige W Lewis, et al.
Vaccine|December 25, 2019
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017John R Su, Penina Haber, Carmen S Ng, et al.
Vaccine|June 15, 2023
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022Emily Jane Woo, Julianne Gee, Paige Marquez, et al.
Vaccine|January 20, 2023
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022Pedro L Moro, Bicheng Zhang, Carol Ennulat, et al.
Pageof 6